ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
类 HDAC 抑制剂莫西替诺他可逆转癌细胞中与 ZEB1 相关的耐药性
期刊:EMBO Molecular Medicine
影响因子:9
doi:10.15252/emmm.201404396
Simone Meidhof, Simone Brabletz, Waltraut Lehmann, Bogdan-Tiberius Preca, Kerstin Mock, Manuel Ruh, Julia Schüler, Maria Berthold, Anika Weber, Ulrike Burk, Michael Lübbert, Martin Puhr, Zoran Culig, Ulrich Wellner, Tobias Keck, Peter Bronsert, Simon Küsters, Ulrich T Hopt, Marc P Stemmler, Thomas B